DeepMed Research

BAYER AG

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Public

Established: 1863-08-01

Employees: 99.7K

Market Cap: $30.1B

Website: http://www.bayer.com

Clinical Trials

An Observational Study to Learn More About Vasomotor Symptoms Burden and Treatment Patterns in Menopausal Women Before and After Participating in OASIS Studies

Not yet recruiting

Conditions: Vasomotor Symptoms (VMS) Associated With Menopause

First Posted Date: 2025-04-29

Last Posted Date: 2025-04-29

Lead Sponsor: Bayer

Target Recruit Count: 250

Registration Number: NCT06949553

Locations: 🇺🇸
Bayer US, Whippany, New Jersey, United States

A Study to Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema

Not yet recruiting

Conditions: Neovascular Age-related Macular Degeneration (nAMD)
Diabetic Macular Edema (DME)

Interventions: Drug: Aflibercept (Eylea, BAY86-5321)

First Posted Date: 2025-04-16

Last Posted Date: 2025-04-16

Lead Sponsor: Bayer

Target Recruit Count: 3000

Registration Number: NCT06929143

Locations: 🇯🇵
Bayer, Osaka, Japan

A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors

Phase 1

Recruiting

Conditions: MTAP-deleted Solid Tumors

Interventions: Drug: BAY3713372

First Posted Date: 2025-04-06

Last Posted Date: 2025-04-24

Lead Sponsor: Bayer

Target Recruit Count: 70

Registration Number: NCT06914128

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust | Sutton - Oak Foundation Drug Development Unit, London, Greater London, United Kingdom
🇬🇧
The Christie NHS Foundation Trust | Christie Hospital - Experimental Cancer Medicine Team, Manchester, United Kingdom
🇺🇸
Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States

and more 9 locations

A Study to Learn How Well Mirena Works as Compared to Oral Progestin in Nonatypical Endometrial Hyperplasia in Women Who Have Started Their Periods

Phase 3

Not yet recruiting

Conditions: Endometrial Hyperplasia

Interventions: Combination Product: BAY865028
Drug: Medroxyprogesterone acetate

First Posted Date: 2025-04-01

Last Posted Date: 2025-05-04

Lead Sponsor: Bayer

Target Recruit Count: 300

Registration Number: NCT06904274

Locations: 🇨🇳
Chongqing Maternal and Child Health Care Hospital, Chongqing, China
🇺🇸
Axia Women's Health, Oaks, Pennsylvania, United States
🇺🇸
AMR - Mobile, AL, Mobile, Alabama, United States

and more 51 locations

An Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men With Metastatic Hormone Sensitive Prostate Cancer in Routine Medical Care

Active, not recruiting

Conditions: Metastatic Hormone-sensitive Prostate Cancer

First Posted Date: 2025-03-13

Last Posted Date: 2025-05-13

Lead Sponsor: Bayer

Target Recruit Count: 700

Registration Number: NCT06874114

Locations: 🇨🇦
Pentavere, Toronto, Ontario, Canada

A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

Phase 1

Recruiting

Conditions: Sepsis
Coagulopathy

Interventions: Drug: BAY3389934

First Posted Date: 2025-03-03

Last Posted Date: 2025-05-06

Lead Sponsor: Bayer

Target Recruit Count: 32

Registration Number: NCT06854640

Locations: 🇧🇪
UZ Antwerpen - Intensive Care, Edegem, Belgium
🇧🇪
Centre Hospitalier Universitaire (CHU) de Liege - Domaine Universitaire du Sart Tilman - Intensive Care, Liege, Belgium
🇧🇪
Clinique Saint-Pierre d'Ottignies - Intensive Care, Ottignies-Louvain-La-Neuve, Belgium

and more 17 locations

The Association Between IL17, Acute Respiratory Distress Syndrome and Acute Respiratory Failure

Completed

Conditions: Acute Respiratory Distress Syndrome (ARDS)
Acute Respiratory Failure (ARF)

First Posted Date: 2025-01-17

Last Posted Date: 2025-02-07

Lead Sponsor: Bayer

Target Recruit Count: 414

Registration Number: NCT06779942

Locations: 🇫🇷
Hôpital Saint Louis, Paris Cedex 10, France
🇫🇷
University Paris Diderot, Paris, France

A Study to Understand How Post-operative Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung Machine

Not Applicable

Recruiting

Conditions: Post-operative Acute Kidney Injury

First Posted Date: 2025-01-13

Last Posted Date: 2025-05-04

Lead Sponsor: Bayer

Target Recruit Count: 200

Registration Number: NCT06772025

Locations: 🇬🇧
Royal Papworth Hospital NHS Foundation Trust | Royal Papworth Hospital - Cardiac Surgery, Cambridge, United Kingdom
🇩🇪
Herz- und Diabeteszentrum Nordrhein-Westfalen (HDZ NRW), Bad Oeynhausen, Nordrhein-Westfalen, Germany
🇬🇧
Guy's and St Thomas' NHS Foundation Trust, Harefield Hospital - Cardiology, Harefield, London, United Kingdom

An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are Related

Active, not recruiting

Conditions: Sepsis
Venous Thromboembolism
Disseminated Intravascular Coagulation

First Posted Date: 2025-01-09

Last Posted Date: 2025-05-04

Lead Sponsor: Bayer

Target Recruit Count: 10000

Registration Number: NCT06765681

Locations: 🇺🇸
Bayer, Whippany, New Jersey, United States

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice

Not yet recruiting

Conditions: Chronic Kidney Disease
Type 2 Diabetes Mellitus

Interventions: Drug: Finerenone (Kerendia, BAY948862)

First Posted Date: 2025-01-08

Last Posted Date: 2025-04-23

Lead Sponsor: Bayer

Target Recruit Count: 1200

Registration Number: NCT06763146

Locations: 🇮🇳
Many locations, Multiple Locations, India

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy